Literature DB >> 25322080

Drug and vaccine access in the Ebola epidemic: advising caution in compassionate use.

Andrew Hantel, Christopher Olusola Olopade.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25322080     DOI: 10.7326/M14-2002

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  7 in total

1.  Hegemonic structure of basic, clinical and patented knowledge on Ebola research: a US army reductionist initiative.

Authors:  David Fajardo-Ortiz; José Ortega-Sánchez-de-Tagle; Victor M Castaño
Journal:  J Transl Med       Date:  2015-04-19       Impact factor: 5.531

2.  Ebola virus infection: what should be known?

Authors:  Viroj Wiwanitkit
Journal:  N Am J Med Sci       Date:  2014-11

3.  Compassionate use of experimental therapies: who should decide?

Authors:  Patricia J Zettler
Journal:  EMBO Mol Med       Date:  2015-10       Impact factor: 12.137

Review 4.  A Systematic Review of Ebola Treatment Trials to Assess the Extent to Which They Adhere to Ethical Guidelines.

Authors:  Thomas Richardson; Andrew McDonald Johnston; Heather Draper
Journal:  PLoS One       Date:  2017-01-17       Impact factor: 3.240

5.  Real Time Monitoring of Children, and Adults with Mental Disabilities Using a Low-Cost Non-Invasive Electronic Device.

Authors:  Carlos Polanco; Ignacio Islas Vazquez; Adrian Martinez-Rivas; Miguel Arias-Estrada; Thomas Buhse; Juan J Calva; Carlos Aguilar Salinas; Claudia Pimentel Hernández; Vladimir N Uversky
Journal:  Micromachines (Basel)       Date:  2017-09-28       Impact factor: 2.891

Review 6.  Early access programs: Benefits, challenges, and key considerations for successful implementation.

Authors:  Sanjaykumar Patil
Journal:  Perspect Clin Res       Date:  2016 Jan-Mar

Review 7.  Taking the bull by the horns: Ethical considerations in the design and implementation of an Ebola virus therapy trial.

Authors:  Francis Kombe; Morenike O Folayan; Jennyfer Ambe; Adaora Igonoh; Akin Abayomi
Journal:  Soc Sci Med       Date:  2015-11-30       Impact factor: 4.634

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.